Detection of Epstein-Barr Virus DNA in Langerhans Cell Histiocytosis

被引:5
|
作者
Khoddami, Maliheh [1 ]
Nadji, Seyed Alireza [2 ]
Dehghanian, Paria [3 ]
Vahdatinia, Mahsa [4 ]
Shamshiri, Ahmad Reza [5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Pathol, Pediat Pathol Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Pediat Infect Dis Res Ctr, Dept Pathol, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Dept Pathol, Tehran, Iran
[5] Univ Tehran Med Sci, Dent Res Inst, Sch Dent, Dept Community Oral Hlth,Dent Res Ctr, Tehran, Iran
关键词
Histiocytosis; Langerhans-Cell; Epstein-Barr Virus Infections; Polymerase Chain Reaction; Dendritic Cells; Cell Proliferation; DENDRITIC CELLS; INFECTION; LYMPHOMA;
D O I
10.5812/jjm.27219
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Langerhans cell histiocytosis (LCH) is a rare histiocytic proliferation of unknown etiology. It is characterized by granuloma-like proliferation of Langerhans-type dendritic cells and mainly affects young children. Although multiple investigators have suggested the possible role of viruses, such as Epstein-Barr virus (EBV), human herpesvirus-6 (HHV-6), Herpes simplex virus (HSV) types 1 and 2, and Cytomegalovirus (CMV) in the pathogenesis of LCH, it remains, however, debated. Objectives: The EBV infection is reported to be associated with LCH. Nevertheless, no report could be found about involved Iranian children in English medical literature. In this study, we investigated the presence of EBV in Iranian children with LCH. Patients and Methods: In this retrospective study, in which we investigated the prevalence of presence of EBV DNA in LCH, using paraffin-embedded tissue samples of 30 patients with LCH and 30 age and tissue-matched controls, who were operated for reasons other than infectious diseases (between the years 2002 and 2012), by real-time polymerase chain reaction (RT-PCR) method, in the department of pediatric pathology. No ethical issues arose in the study, because only the pathology reports were reviewed, retrospectively, and the patients were anonymous. Results: There was a significant difference in prevalence of EBV presence between patients and controls. The EBV was found by RT-PCR in 19 (63.33%) out of 30 patients and only in eight (26.7%) of 30 control samples. The P = 0.004, was calculated using chi-square test (OR: 4.75; 95% CI: 1.58. 14.25). Conclusions: Our study is the first investigation performed on patients with LCH and its possible association with EBV in Iran. Considering the P = 0.004, which is statistically significant, the findings do support the hypothesis of a possible role for EBV in the pathogenesis of LCH. These results are in accordance with several previous investigations, with positive findings.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] DETECTION OF EPSTEIN-BARR VIRUS-DNA IN MOUTHWASHES BY HYBRIDIZATION
    AMBINDER, RF
    WINGARD, JR
    BURNS, WH
    HAYWARD, SD
    SARAL, R
    PERRY, HR
    SANTOS, GW
    HAYWARD, GS
    JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) : 353 - 356
  • [22] Cell-Free Circulating Tumor DNA and Epstein-Barr Virus DNA for Early Diagnosis of Epstein-Barr Virus-Associated Cancers
    Xian, Rena R.
    Ambinder, Richard F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (26) : 4290 - +
  • [23] EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH BRAFV600E+MULTISYSTEM RISK ORGAN INVOLVEMENT LANGERHANS CELL HISTIOCYTOSIS
    Morales, Sonia
    Johnson, Natalie
    Brown, Carol
    Torno, Lilibeth
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [24] Sequential Quantification of Epstein-Barr Virus DNA in a Case of Epstein-Barr Virus—Associated Hemophagocytic Syndrome
    Toru Takahashi
    Eiichi Oeda
    Yutaka Sato
    Yukio Tanizawa
    International Journal of Hematology, 2002, 76 : 290 - 291
  • [25] Quantification of Epstein-Barr Virus DNA Is Helpful for Evaluation of Chronic Active Epstein-Barr Virus Infection
    Sakamoto, Yuichi
    Mariya, Yasushi
    Kubo, Kohmei
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 227 (04): : 307 - 311
  • [26] Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?
    Jones, Kimberley
    Gandhi, Maher K.
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 684 - 686
  • [27] Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions
    Knol, AC
    Quéreux, G
    Pandolfino, MC
    Khammari, A
    Dreno, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (01) : 280 - 282
  • [28] The rational specimen for the quantitative detection of Epstein-Barr virus DNA load
    Wang Kedi
    Xu Dongjiang
    Lv Zhi
    Gao Yan
    Jia Kun
    Su Jianrong
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (05) : 759 - 765
  • [29] Detection of Epstein-Barr virus DNA in a patient with Kimura's disease
    Nagore, E
    Llorca, J
    Sánchez-Motilla, JM
    Ledesma, E
    Fortea, JM
    Aliaga, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (08) : 618 - 620
  • [30] STRUCTURE OF THE TERMINI OF THE DNA OF EPSTEIN-BARR VIRUS
    KINTNER, CR
    SUGDEN, B
    CELL, 1979, 17 (03) : 661 - 671